2byf

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="2byf" size="450" color="white" frame="true" align="right" spinBox="true" caption="2byf" /> '''NMR SOLUTION STRUCTURE OF PHOSPHOLIPASE C EP...)
Line 1: Line 1:
-
[[Image:2byf.gif|left|200px]]<br /><applet load="2byf" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:2byf.gif|left|200px]]<br /><applet load="2byf" size="350" color="white" frame="true" align="right" spinBox="true"
caption="2byf" />
caption="2byf" />
'''NMR SOLUTION STRUCTURE OF PHOSPHOLIPASE C EPSILON RA 2 DOMAIN'''<br />
'''NMR SOLUTION STRUCTURE OF PHOSPHOLIPASE C EPSILON RA 2 DOMAIN'''<br />
==Overview==
==Overview==
-
Ras proteins signal to a number of distinct pathways by interacting with, diverse effectors. Studies of ras/effector interactions have focused on, three classes, Raf kinases, ral guanylnucleotide-exchange factors, and, phosphatidylinositol-3-kinases. Here we describe ras interactions with, another effector, the recently identified phospholipase C epsilon, (PLCepsilon). We solved structures of PLCepsilon RA domains (RA1 and RA2), by NMR and the structure of the RA2/ras complex by X-ray crystallography., Although the similarity between ubiquitin-like folds of RA1 and RA2 proves, that they are homologs, only RA2 can bind ras. Some of the features of the, RA2/ras interface are unique to PLCepsilon, while the ability to make, contacts with both switch I and II regions of ras is shared only with, phosphatidylinositol-3-kinase. Studies of PLCepsilon regulation suggest, that, in a cellular context, the RA2 domain, in a mode specific to, PLCepsilon, has a role in membrane targeting with further regulatory, impact on PLC activity.
+
Ras proteins signal to a number of distinct pathways by interacting with diverse effectors. Studies of ras/effector interactions have focused on three classes, Raf kinases, ral guanylnucleotide-exchange factors, and phosphatidylinositol-3-kinases. Here we describe ras interactions with another effector, the recently identified phospholipase C epsilon (PLCepsilon). We solved structures of PLCepsilon RA domains (RA1 and RA2) by NMR and the structure of the RA2/ras complex by X-ray crystallography. Although the similarity between ubiquitin-like folds of RA1 and RA2 proves that they are homologs, only RA2 can bind ras. Some of the features of the RA2/ras interface are unique to PLCepsilon, while the ability to make contacts with both switch I and II regions of ras is shared only with phosphatidylinositol-3-kinase. Studies of PLCepsilon regulation suggest that, in a cellular context, the RA2 domain, in a mode specific to PLCepsilon, has a role in membrane targeting with further regulatory impact on PLC activity.
==About this Structure==
==About this Structure==
-
2BYF is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2BYF OCA].
+
2BYF is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2BYF OCA].
==Reference==
==Reference==
Line 13: Line 13:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Bunney, T.D.]]
+
[[Category: Bunney, T D.]]
-
[[Category: Driscoll, P.C.]]
+
[[Category: Driscoll, P C.]]
[[Category: Esposito, D.]]
[[Category: Esposito, D.]]
-
[[Category: Gandarillas, N.L.]]
+
[[Category: Gandarillas, N L.]]
[[Category: Gieschik, P.]]
[[Category: Gieschik, P.]]
[[Category: Harris, R.]]
[[Category: Harris, R.]]
-
[[Category: Josephs, M.B.]]
+
[[Category: Josephs, M B.]]
[[Category: Katan, M.]]
[[Category: Katan, M.]]
-
[[Category: Paterson, H.F.]]
+
[[Category: Paterson, H F.]]
-
[[Category: Pearl, L.H.]]
+
[[Category: Pearl, L H.]]
[[Category: Rodrigues-Lima, F.]]
[[Category: Rodrigues-Lima, F.]]
-
[[Category: Roe, S.M.]]
+
[[Category: Roe, S M.]]
[[Category: lipase]]
[[Category: lipase]]
[[Category: phospholipase c epsilon]]
[[Category: phospholipase c epsilon]]
Line 30: Line 30:
[[Category: ubiquitin superfold]]
[[Category: ubiquitin superfold]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 08:57:36 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:43:00 2008''

Revision as of 14:43, 21 February 2008


2byf

Drag the structure with the mouse to rotate

NMR SOLUTION STRUCTURE OF PHOSPHOLIPASE C EPSILON RA 2 DOMAIN

Overview

Ras proteins signal to a number of distinct pathways by interacting with diverse effectors. Studies of ras/effector interactions have focused on three classes, Raf kinases, ral guanylnucleotide-exchange factors, and phosphatidylinositol-3-kinases. Here we describe ras interactions with another effector, the recently identified phospholipase C epsilon (PLCepsilon). We solved structures of PLCepsilon RA domains (RA1 and RA2) by NMR and the structure of the RA2/ras complex by X-ray crystallography. Although the similarity between ubiquitin-like folds of RA1 and RA2 proves that they are homologs, only RA2 can bind ras. Some of the features of the RA2/ras interface are unique to PLCepsilon, while the ability to make contacts with both switch I and II regions of ras is shared only with phosphatidylinositol-3-kinase. Studies of PLCepsilon regulation suggest that, in a cellular context, the RA2 domain, in a mode specific to PLCepsilon, has a role in membrane targeting with further regulatory impact on PLC activity.

About this Structure

2BYF is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Structural and mechanistic insights into ras association domains of phospholipase C epsilon., Bunney TD, Harris R, Gandarillas NL, Josephs MB, Roe SM, Sorli SC, Paterson HF, Rodrigues-Lima F, Esposito D, Ponting CP, Gierschik P, Pearl LH, Driscoll PC, Katan M, Mol Cell. 2006 Feb 17;21(4):495-507. PMID:16483931

Page seeded by OCA on Thu Feb 21 16:43:00 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools